Green Cross Health Limited Ordinary Shares
GXH.NZXHealth Care
Overview Green Cross Health is a provider of primary health care services to communities throughout New Zealand and supports a network of around 360 pharmacies, 41 medical centres, and provides community health care and nursing services to more than 30,500 people throughout New Zealand. History The business was first listed as Beauty Direct Online Ltd in March 2000. In February 2005 shareholders approved the acquisition of the business of Life Pharmacy and a 49% shareholding in 17 companies operating Life Pharmacies and in March 2005 the company changed its name to Life Pharmacy Ltd (NZX: LPL). In May 2008 LPL acquired Care Chemist Ltd and in 2009, the company merged with Pharmacybrands, a group which included Unichem and Amcal pharmacies. In 2010 the company changed its name from Life Pharmacy Limited to Pharmacybrands Limited (NZX: PHB). The 2011 acquisition of Radius Pharmacy, Radius Medical Limited and Radius Medical Solutions Limited marked a transition to becoming a provider of broader healthcare services. Investment in community care specialist Total Care Health Services in 2014 was followed by the change of company name from Pharmacybrands to Green Cross Health (NZX: GXH) to better reflect the full scope of primary health care services the company offers. The acquisition of Access Homehealth, also in 2014, gave Green Cross Health significant presence in the community health care market, with more than 4,000 support workers and nurses. The company continued to extend its presence in medical services, growing the number of practices and patients with the acquisitions of Tucker Consulting, a management services company serving six medical practices and Peak Primary, a group of 12 wholly owned general practice. By mid-2015, the process of pharmacy rebranding started in 2013 was nearing completion, with the retirement of Amcal, Care Chemist and Radius Pharmacy brands in New Zealand and the growing pharmacy network consolidating under the Unichem and Life Pharmacy retail brands across 330 stores. In 2015 Green Cross Health also acquired the remaining 50% shareholding in Total Care Health Services Limited, further enhancing the opportunity for growth in the community health market in Auckland.
Market Data
$1.500
+0.0%$215.6M
12.3x
$0.122
5.57%
+0.8%
Latest Earnings
Green Cross Health Full Year Results to 31 March 2026
29 May 2026
Green Cross Health (NZX: GXH) delivered a strong full-year result for the twelve months ended 31 March 2026, with Operating Revenue up 4% to $546.0m and EBIT up 17% to $45.3m. Net Profit After Tax Attributable to Shareholders grew 28% to $20.4m, driven by strong Medical division performance (Operating Profit +33%) and steady Pharmacy growth (Operating Profit +4%). The Board declared a final dividend of 5.50 cents per share, and the company is progressing a potential sale of its Medical division alongside the establishment of a new Primary Health Organisation (PHO) from 1 July 2026. Key points: NPAT attributable to shareholders grew 28% to $20.4m, with EPS of 14.2 cents per share; Medical division delivered exceptional 33% Operating Profit growth to $26.0m, driven by government funding uplift and immunisation-linked incentive payments; Group is now net cash positive at $8.6m with a low gearing ratio of 9.4% and strong operating cash flow of $54.6m
Recent Announcements
Green Cross Health Full Year Results to 31 March 2026
Green Cross Health (NZX: GXH) delivered a strong full-year result for the twelve months ended 31 March 2026, with Operating Revenue up 4% to $546.0m and EBIT up 17% to $45.3m. Net Profit After Tax Attributable to Shareholders grew 28% to $20.4m, driven by strong Medical division performance (Operating Profit +33%) and steady Pharmacy growth (Operating Profit +4%). The Board declared a final dividend of 5.50 cents per share, and the company is progressing a potential sale of its Medical division alongside the establishment of a new Primary Health Organisation (PHO) from 1 July 2026. Key points: NPAT attributable to shareholders grew 28% to $20.4m, with EPS of 14.2 cents per share; Medical division delivered exceptional 33% Operating Profit growth to $26.0m, driven by government funding uplift and immunisation-linked incentive payments; Group is now net cash positive at $8.6m with a low gearing ratio of 9.4% and strong operating cash flow of $54.6m
Response to media report
Green Cross Health (NZX: GXH) has confirmed media reports that it is in discussions with third parties regarding a potential sale of its Medical division. The company provided no financial details or transaction terms, and explicitly noted there is no certainty any deal will proceed. This is a strategic/corporate update rather than an earnings announcement. Key points: Green Cross Health confirmed it is actively engaging with parties regarding a potential transaction involving its Medical division (operating as 'The Doctors'); The Medical division includes 65 medical centres with over 400,000 enrolled patients, representing a significant asset; Company committed to continuous disclosure obligations, signalling ongoing shareholder communication if a transaction progresses
Get real-time alerts for GXH
Receive AI-powered earnings summaries and instant notifications when Green Cross Health Limited Ordinary Shares releases results.
Register Free